These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 3912685

  • 1. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC.
    Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685
    [Abstract] [Full Text] [Related]

  • 2. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
    Trevor AJ, Castagnoli N, Caldera P, Ramsay RR, Singer TP.
    Life Sci; 1987 Feb 23; 40(8):713-9. PubMed ID: 3492651
    [Abstract] [Full Text] [Related]

  • 3. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ.
    Nature; 1987 Feb 23; 319(6048):56-7. PubMed ID: 3484542
    [Abstract] [Full Text] [Related]

  • 4. MPTP, MPP+ and mitochondrial function.
    Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE.
    Life Sci; 1987 Feb 23; 40(8):721-9. PubMed ID: 3100899
    [Abstract] [Full Text] [Related]

  • 5. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM, Arora PK, Iacofano LA, Harik SI.
    Eur J Pharmacol; 1986 May 13; 124(1-2):171-4. PubMed ID: 3487462
    [Abstract] [Full Text] [Related]

  • 6. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
    Heikkila RE, Hwang J, Ofori S, Geller HM, Nicklas WJ.
    J Neurochem; 1990 Mar 13; 54(3):743-50. PubMed ID: 2303810
    [Abstract] [Full Text] [Related]

  • 7. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I, Heikkila RE, Nicklas WJ.
    J Neurochem; 1986 May 13; 46(5):1501-7. PubMed ID: 3485701
    [Abstract] [Full Text] [Related]

  • 8. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI, Schmidley JW, Iacofano LA, Blue P, Arora PK, Sayre LM.
    J Pharmacol Exp Ther; 1987 May 13; 241(2):669-76. PubMed ID: 2437293
    [Abstract] [Full Text] [Related]

  • 9. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA, Kindt MV, Heikkila RE.
    J Neurochem; 1986 Oct 13; 47(4):1073-9. PubMed ID: 3489072
    [Abstract] [Full Text] [Related]

  • 10. Astrocytes as a primary locus for the conversion MPTP into MPP+.
    Brooks WJ, Jarvis MF, Wagner GC.
    J Neural Transm; 1989 Oct 13; 76(1):1-12. PubMed ID: 2785159
    [Abstract] [Full Text] [Related]

  • 11. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV, Heikkila RE, Nicklas WJ.
    J Pharmacol Exp Ther; 1987 Sep 13; 242(3):858-63. PubMed ID: 3498818
    [Abstract] [Full Text] [Related]

  • 12. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Peterson LA, Caldera PS, Trevor A, Chiba K, Castagnoli N.
    J Med Chem; 1985 Oct 13; 28(10):1432-6. PubMed ID: 3876442
    [Abstract] [Full Text] [Related]

  • 13. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
    Trevor AJ, Singer TP, Ramsay RR, Castagnoli N.
    J Neural Transm Suppl; 1987 Oct 13; 23():73-89. PubMed ID: 3295117
    [Abstract] [Full Text] [Related]

  • 14. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 15. Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.
    Sun CJ, Johannessen JN, Gessner W, Namura I, Singhaniyom W, Brossi A, Chiueh CC.
    J Neural Transm; 1988 Aug 05; 74(2):75-86. PubMed ID: 3266233
    [Abstract] [Full Text] [Related]

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver.
    Thakar JH, Hassan MN, Grimes JD.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Aug 05; 12(2-3):355-62. PubMed ID: 3260387
    [Abstract] [Full Text] [Related]

  • 17. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE, Sanchez-Ramos JR, Sick TJ, Rosenthal M.
    Brain Res; 1988 Dec 20; 475(2):283-90. PubMed ID: 3265070
    [Abstract] [Full Text] [Related]

  • 18. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ, Costall B, Domeney AM, Testa B, Jenner PG, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Oct 24; 61(1-2):121-6. PubMed ID: 2417166
    [Abstract] [Full Text] [Related]

  • 19. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C.
    J Neurochem; 1989 Oct 24; 53(4):1149-55. PubMed ID: 2788714
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H, Mason MF, Debler EA, Lajtha A.
    Eur J Pharmacol; 1986 Jul 31; 126(3):337-9. PubMed ID: 3489627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.